The estimated Net Worth of Michael J Pederson is at least $10.1 Million dollars as of 8 September 2021. Mr. Pederson owns over 23,008 units of Abbott Laboratories stock worth over $9,978,511 and over the last 7 years he sold ABT stock worth over $93,816. In addition, he makes $0 as Senior Vice President - Electrophysiology and Heart Failure at Abbott Laboratories.
Michael has made over 5 trades of the Abbott Laboratories stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 23,008 units of ABT stock worth $1,166,966 on 8 September 2021.
The largest trade he's ever made was exercising 23,008 units of Abbott Laboratories stock on 8 September 2021 worth over $1,166,966. On average, Michael trades about 2,821 units every 52 days since 2017. As of 8 September 2021 he still owns at least 85,579 units of Abbott Laboratories stock.
You can see the complete history of Mr. Pederson stock trades at the bottom of the page.
Michael J. Pederson serves as Senior Vice President - Electrophysiology and Heart Failure of the Company. Divisional Vice President and General Manager, Abbott Electrophysiology from 2015-2017. Chief Executive Officer, VytronUS, Inc. (a medical device company focused on developing electrophysiology technologies) from 2011-2015.
Michael Pederson is 58, he's been the Senior Vice President - Electrophysiology and Heart Failure of Abbott Laboratories since 2019. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Michael's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, and Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: